Given Bio-Rad Laboratories' mixed past earnings performance and the significant stock price decline over the past year, the upcoming earnings report is crucial. However, the impact of the earnings report on the stock price is uncertain, as it will heavily depend on whether the company meets or exceeds the EPS estimate and provides positive future guidance. The historical data suggests that the company's stock is sensitive to earnings announcements, but investor sentiment and market conditions at the time of the release will also play critical roles.